Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | LYPLA1 | O75608 | 1/20 | 0.31 |
| ▸ | LYPLA2 | O95372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28238302 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRDNM1CA2HSD17B10 | |
| SCHEMBL3115464 | 0.92 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1CA2HSD17B10 | |
| Fluoride SCHEMBL28239233 | 0.82 | CA2 (0.50) | DNM1CA2THRBTHRACA1 | |
| SCHEMBL425349 | 0.81 | — | — | |
| Ammonia Solution, Strong SCHEMBL27689607 | 0.79 | ALDH1A1 (0.36) | ALDH1A1TSHRCA2TDP1CA12 | |
| SCHEMBL10457263 | 0.78 | CA2 (0.43) | TSHRCA2CA12CA1CA14 | |
| SCHEMBL14885530 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1CA2THRB | |
| SCHEMBL20760744 | 0.76 | NPSR1 (0.44) | ALDH1A1CA2CA12CA1CA14 | |
| SCHEMBL353885 | 0.75 | ALDH1A1 (0.48) | ALDH1A1TSHRDNM1HSD17B10THRB | |
| SCHEMBL7380106 | 0.75 | ALDH1A1 (0.48) | ALDH1A1TSHRDNM1CA2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12285704-B2 | Sulfonamide based anion exchange resins | DIONEX CORPORATION (US) | 2025-04-29 | — | — | US | disclosed |
| CN-108430967-B | Preparation of sulfonamide-containing antimicrobial agents and matrix treatment compositions comprising sulfonamide-containing antimicrobial agents | 纳米安全涂层公司（佛罗里达公司3 P 14000024914) | 2024-12-13 | — | — | CN | disclosed |
| US-11773058-B2 | Sulfonamide carboxamide compounds | INFLAZOME LIMITED (IE) | 2023-10-03 | — | — | US | disclosed |
| US-11773058-B2 | Sulfonamide carboxamide compounds | INFLAZOME LIMITED (IE) | 2023-10-03 | — | — | US | disclosed |
| US-11773058-B2 | Sulfonamide carboxamide compounds | INFLAZOME LIMITED (IE) | 2023-10-03 | — | — | US | disclosed |
| US-20210308599-A1 | SULFONAMIDE BASED ANION EXCHANGE RESINS | DIONEX CORPORATION | 2021-10-07 | — | — | US | disclosed |
| US-20200331850-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2020-10-22 | — | — | US | disclosed |
| US-20200331850-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2020-10-22 | — | — | US | disclosed |
| CN-111107903-A | Novel sulfonamide carboxamide compounds | 英夫拉索姆有限公司 | 2020-05-05 | — | — | CN | disclosed |
| WO-2019034696-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2019-02-21 | — | — | WO | disclosed |
| CN-108430967-A | The preparation of the matrix treatments composition of antimicrobial containing sulfanilamide (SN) and the antimicrobial containing sulfanilamide (SN) | 纳米安全涂层公司（佛罗里达公司3 P 14000024914) | 2018-08-21 | — | — | CN | disclosed |
| WO-2013065878-A1 | METHOD OF FORMING PATTERN AND COMPOSITION FOR CROSSLINKED LAYER FORMATION TO BE USED IN THE METHOD | FUJIFILM CORPORATION (JP) | 2013-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773058-B2 | Sulfonamide carboxamide compounds | NLRP3, NOD1, NLRP1 | ALDH1A1 1414/4885TSHR 1360/4885DNM1 3534/4885 |
| US-20200331850-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | NLRP3, NOD1, NLRP1 | ALDH1A1 1729/4885TSHR 1420/4885DNM1 3582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.